Jacek Rubik

588 total citations
35 papers, 322 citations indexed

About

Jacek Rubik is a scholar working on Transplantation, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jacek Rubik has authored 35 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Transplantation, 9 papers in Nephrology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jacek Rubik's work include Renal Transplantation Outcomes and Treatments (14 papers), Organ Transplantation Techniques and Outcomes (6 papers) and Renal Diseases and Glomerulopathies (5 papers). Jacek Rubik is often cited by papers focused on Renal Transplantation Outcomes and Treatments (14 papers), Organ Transplantation Techniques and Outcomes (6 papers) and Renal Diseases and Glomerulopathies (5 papers). Jacek Rubik collaborates with scholars based in Poland, Germany and Italy. Jacek Rubik's co-authors include Ryszard Grenda, Barbara Piątosa, Karlijn J. van Stralen, Enrico Verrina, Kitty J. Jager, Burkhard Tönshoff, Augustina Jankauskienė, Franz Schaefer, T. Pawiński and Piotr Kaliciński and has published in prestigious journals such as International Journal of Molecular Sciences, American Journal of Transplantation and Clinica Chimica Acta.

In The Last Decade

Jacek Rubik

32 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacek Rubik Poland	10	129	120	80	78	61	35	322
Nicholas Larkins Australia	11	78 0.6×	138 1.1×	56 0.7×	95 1.2×	74 1.2×	46	373
B. Erbay Türkiye	11	69 0.5×	124 1.0×	80 1.0×	42 0.5×	32 0.5×	20	401
B. Klare Germany	12	201 1.6×	65 0.5×	104 1.3×	103 1.3×	125 2.0×	23	441
Somratai Vadcharavivad Thailand	12	154 1.2×	101 0.8×	54 0.7×	22 0.3×	71 1.2×	26	346
Constantino Fernández Rivera Spain	10	134 1.0×	151 1.3×	130 1.6×	47 0.6×	14 0.2×	24	374
M. González-Molina Spain	13	330 2.6×	80 0.7×	195 2.4×	105 1.3×	36 0.6×	49	507
G. Chong France	11	179 1.4×	130 1.1×	130 1.6×	34 0.4×	55 0.9×	26	424
Pranav Dalal United States	7	126 1.0×	98 0.8×	95 1.2×	31 0.4×	21 0.3×	14	307
Margarita Villa Italy	7	254 2.0×	74 0.6×	155 1.9×	70 0.9×	29 0.5×	9	377
J. Nauta Netherlands	9	59 0.5×	89 0.7×	57 0.7×	109 1.4×	139 2.3×	18	379

Countries citing papers authored by Jacek Rubik

Since Specialization

Citations

This map shows the geographic impact of Jacek Rubik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacek Rubik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacek Rubik more than expected).

Fields of papers citing papers by Jacek Rubik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacek Rubik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacek Rubik. The network helps show where Jacek Rubik may publish in the future.

Co-authorship network of co-authors of Jacek Rubik

This figure shows the co-authorship network connecting the top 25 collaborators of Jacek Rubik. A scholar is included among the top collaborators of Jacek Rubik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacek Rubik. Jacek Rubik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rubik, Jacek, et al.. (2025). The comparison of two volumetric microsampling devices (qDBS and VAMS) for determining ganciclovir levels in capillary blood using the LC-MS/MS technique in pediatric renal transplant recipients. European Journal of Pharmaceutical Sciences. 212. 107200–107200.

Rubik, Jacek, et al.. (2024). Personalization of pharmacotherapy with sirolimus based on volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients—from LC-MS/MS method validation to clinical application. Pharmacological Reports. 76(6). 1443–1455. 2 indexed citations

Rubik, Jacek, et al.. (2024). Assessment of Dried Serum Spots (DSS) and Volumetric-Absorptive Microsampling (VAMS) Techniques in Therapeutic Drug Monitoring of (Val)Ganciclovir—Comparative Study in Analytical and Clinical Practice. International Journal of Molecular Sciences. 25(16). 8760–8760. 3 indexed citations

Rubik, Jacek, et al.. (2023). Therapeutic Drug Monitoring of Tacrolimus Based on Volumetric Absorptive Microsampling Technique (VAMS) in Renal Transplant Pediatric Recipients—LC-MS/MS Method Development, Hematocrit Effect Evaluation, and Clinical Application. Pharmaceutics. 15(1). 299–299. 9 indexed citations

Rubik, Jacek, et al.. (2023). Therapeutic drug monitoring of mycophenolic acid (MPA) using volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients: ultra-high-performance liquid chromatography-tandem mass spectrometry analytical method development, cross-validation, and clinical application. Pharmacological Reports. 75(4). 1026–1042. 10 indexed citations

Sikora, Przemysław, Ryszard Grenda, Małgorzata Kowalczyk, et al.. (2022). Nephropathic cystinosis in Poland: a 40-year retrospective study. Polskie Archiwum Medycyny Wewnętrznej. 132(11).

Rubik, Jacek, Dominique Debray, Déirdre Kelly, et al.. (2019). Efficacy and safety of prolonged‐release tacrolimus in stable pediatric allograft recipients converted from immediate‐release tacrolimus – a Phase 2, open‐label, single‐arm, one‐way crossover study. Transplant International. 32(11). 1182–1193. 6 indexed citations

Rubik, Jacek, Dominique Debray, Franck Iserin, et al.. (2019). Comparative pharmacokinetics of tacrolimus in stable pediatric allograft recipients converted from immediate‐release tacrolimus to prolonged‐release tacrolimus formulation. Pediatric Transplantation. 23(4). e13391–e13391. 5 indexed citations

Runowski, Dariusz, et al.. (2018). Therapeutic Plasma Exchange in Pediatric Renal Transplantation Experience of One Decade and 389 Sessions. Transplantation Proceedings. 50(10). 3483–3486. 4 indexed citations

10.

Szymczak, Marek, Piotr Kaliciński, Dorota Broniszczak, et al.. (2018). Combined Liver-Kidney Transplantation in Children: Single-Center Experiences and Long-Term Results. Transplantation Proceedings. 50(7). 2140–2144. 7 indexed citations

11.

Grenda, Ryszard, et al.. (2016). Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome. European Journal of Pediatrics. 175(9). 1133–1137. 12 indexed citations

12.

Zagożdżon, Ilona, Aleksandra Żurowska, Jacek Rubik, et al.. (2014). Do children with end-stage renal disease live shorter? Analysis of mortality on the basis of data from the Polish Registry of Renal Replacement Therapy in Children. Advances in Medical Sciences. 60(1). 13–17. 2 indexed citations

13.

Harambat, Jérôme, Karlijn J. van Stralen, Franz Schaefer, et al.. (2013). Disparities in Policies, Practices and Rates of Pediatric Kidney Transplantation in Europe. American Journal of Transplantation. 13(8). 2066–2074. 67 indexed citations

14.

Stralen, Karlijn J. van, Enrico Verrina, Jaap W. Groothoff, et al.. (2013). Underweight, overweight and obesity in paediatric dialysis and renal transplant patients. Nephrology Dialysis Transplantation. 28(suppl 4). iv195–iv204. 45 indexed citations

15.

Grenda, Ryszard, et al.. (2010). Bone mineral disease in children after renal transplantation in steroid‐free and steroid‐treated patients – a prospective study. Pediatric Transplantation. 15(2). 205–213. 11 indexed citations

16.

Grenda, Ryszard, et al.. (2010). Long‐term effect of rituximab in maintaining remission of recurrent and plasmapheresis‐dependent nephrotic syndrome post‐renal transplantation – Case report. Pediatric Transplantation. 15(6). E121–5. 22 indexed citations

17.

Piątosa, Barbara, et al.. (2009). Skuteczność rituximabu w leczeniu nawrotu zespołu nerczycowego po transplantacji nerki o przebiegu klinicznym zależnym od plazmaferezy - opis przypadku. Via Medica Journals. 2(4). 246–249.

18.

Piątosa, Barbara, Jacek Rubik, & Ryszard Grenda. (2006). Is Positive Flow Cytometric Cross-Match a Risk Factor for Early Cadaveric Kidney Graft Dysfunction?. Transplantation Proceedings. 38(1). 53–55. 7 indexed citations

19.

Rubik, Jacek, Andrzej Kamiński, Sergiusz Jóźwiak, et al.. (2004). Successful treatment of a child with fulminant liver failure and coma caused by Amanita phalloides intoxication with albumin dialysis without liver transplantation. Pediatric Transplantation. 8(3). 295–300. 20 indexed citations

20.

Piątosa, Barbara, et al.. (2002). The significance of anti-HLA antibody presence in children who lost the transplanted kidney due to vascular thrombosis. Transplantation Proceedings. 34(2). 589–590. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact